Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array Approach
Open Access
- 6 December 2005
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 3 (1) , e2
- https://doi.org/10.1371/journal.pmed.0030002
Abstract
Systemic sclerosis is an autoimmune disease characterized by immunological abnormalities, vascular damage, and fibroblast proliferation. We have previously shown that a molecular mimicry mechanism links antibodies against the human-cytomegalovirus-derived protein UL94 to the pathogenesis of systemic sclerosis. The UL94 epitope shows homology with NAG-2, a surface molecule highly expressed on endothelial cells. Anti-UL94 peptide antibodies purified from patients' sera induce apoptosis of endothelial cells upon engagement of the NAG-2–integrin complex. We show here that NAG-2 is expressed on dermal fibroblasts and that anti-UL94 antibodies bind to fibroblasts. We have used the gene array strategy (Affimetrix oligonucleotide microarrays) to analyze the transcriptional profile in response to a 4-h and an 8-h treatment with antibodies against the UL94 peptide in endothelial cells and dermal fibroblasts. Exposure of endothelial cells to anti-UL94 antibodies had a profound impact on gene expression, resulting in the upregulation of 1,645 transcripts. Several gene clusters were upregulated including genes encoding adhesion molecules, chemokines, colony-stimulating factors (CSFs), growth factors, and molecules involved in apoptosis. Following antibody stimulation, dermal fibroblasts showed an upregulation of 989 transcripts and acquired a “scleroderma-like” phenotype. Indeed, genes involved in extracellular matrix deposition, growth factors, chemokines, and cytokines were upregulated. We confirmed the microarray results by real-time quantitative polymerase chain reaction and by measuring some of the corresponding proteins with ELISA and Western blotting. Our results show that anti-human-cytomegalovirus antibodies may be linked to the pathogenesis of systemic sclerosis not only by inducing endothelial cell activation and apoptosis but also by causing activation of fibroblasts, one of the hallmarks of the disease.Keywords
This publication has 67 references indexed in Scilit:
- Scleroderma Fibroblasts Demonstrate Enhanced Activation of Akt (Protein Kinase B) In SituJournal of Investigative Dermatology, 2005
- Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarraysExperimental Hematology, 2004
- A modified model of graft‐versus‐host–induced systemic sclerosis (scleroderma) exhibits all major aspects of the human diseaseArthritis & Rheumatism, 2004
- Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight‐skin mouseArthritis & Rheumatism, 2003
- Epidermal growth factor up‐regulates expression of transforming growth factor β receptor type II in human dermal fibroblasts by phosphoinositide 3‐kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblastsArthritis & Rheumatism, 2003
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic SclerosisJournal of Investigative Dermatology, 2003
- TGF-β induces apoptosis through Smad-mediated expression of DAP-kinaseNature Cell Biology, 2001
- Transforming Growth Factor-β Regulation of Bone Morphogenetic Protein-1/Procollagen C-proteinase and Related Proteins in Fibrogenic Cells and KeratinocytesJournal of Biological Chemistry, 1997
- Endothelin, an endothelial‐dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic actionArthritis & Rheumatism, 1991